FIRST MANHATTAN CO. LLC. - AVIDITY BIOSCIENCES INC ownership

AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 142 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 6.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of AVIDITY BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,276
-42.5%
2000.0%0.00%
Q2 2023$2,218
-27.8%
2000.0%0.00%
Q1 2023$3,070
-30.8%
2000.0%0.00%
Q4 2022$4,438
+47.9%
2000.0%0.00%
Q3 2022$3,000
+50.0%
2000.0%0.00%
Q2 2022$2,000
-33.3%
2000.0%0.00%
Q1 2022$3,000
-25.0%
2000.0%0.00%
Q4 2021$4,0000.0%2000.0%0.00%
Q3 2021$4,0000.0%2000.0%0.00%
Q2 2021$4,0000.0%2000.0%0.00%
Q1 2021$4,0002000.00%
Other shareholders
AVIDITY BIOSCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 907,567$22,353,00019.68%
5AM Venture Management, LLC 555,555$13,683,0002.78%
Octagon Capital Advisors LP 446,641$11,001,0002.71%
EcoR1 Capital, LLC 2,759,505$67,967,0002.36%
Cormorant Asset Management, LP 2,162,115$53,253,0002.16%
Asymmetry Capital Management, L.P. 126,116$3,106,0001.87%
RTW INVESTMENTS, LP 4,795,000$118,101,0001.78%
Aaron Wealth Advisors LLC 229,595$5,654,0001.59%
Altium Capital Management LP 225,000$5,542,0001.45%
Boxer Capital, LLC 1,121,327$27,618,0000.96%
View complete list of AVIDITY BIOSCIENCES INC shareholders